A detailed history of Marquette Asset Management, LLC transactions in Chimerix Inc stock. As of the latest transaction made, Marquette Asset Management, LLC holds 116,009 shares of CMRX stock, worth $346,866. This represents 0.02% of its overall portfolio holdings.

Number of Shares
116,009
Previous 116,009 -0.0%
Holding current value
$346,866
Previous $102,000 4.9%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$0.91 - $1.26 $20,665 - $28,613
22,709 Added 24.34%
116,009 $122,000
Q4 2023

Feb 02, 2024

SELL
$0.9 - $1.06 $1,153 - $1,358
-1,282 Reduced 1.36%
93,300 $89,000
Q2 2023

Jul 28, 2023

BUY
$1.1 - $1.54 $104,040 - $145,656
94,582 New
94,582 $114,000
Q4 2020

Jan 15, 2021

SELL
$2.43 - $5.42 $44,901 - $100,150
-18,478 Closed
0 $0
Q2 2020

Jul 21, 2020

SELL
$1.33 - $3.63 $23,260 - $63,485
-17,489 Reduced 48.63%
18,478 $57,000
Q1 2020

Apr 08, 2020

BUY
$1.27 - $2.33 $45,678 - $83,803
35,967 New
35,967 $52,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $262M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Marquette Asset Management, LLC Portfolio

Follow Marquette Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marquette Asset Management, LLC with notifications on news.